Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine Development

A Volz1, G Sutter1

  • 1German Center for Infection Research (DZIF), Institute for Infectious Diseases and Zoonoses, LMU University of Munich, Munich, Germany.

Summary

Modified Vaccinia virus Ankara (MVA) is a safe and effective vaccine vector for infectious diseases and cancer. Its unique properties make it a versatile tool for developing novel vaccines against various global health threats.